JPRN-UMIN000005515已完成未知
Efficacy of respiratory quinolones for the treatment of community acquired pneumonia: a randomized controlled trial of moxifloxacin versus garenoxacin. - Comparison between moxifloxacin and garenoxacin for the treatment of community acquired pneumonia.
agasaki evaluation organization for clinical interventions0 个研究点目标入组 120 人开始时间: 2011年4月27日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients who are prohibited to take either moxifloxacin or garenoxacin. 2.Low body weight (less than 40 kg). 3.Severe renal dysfunction (Ccr is less than 30 mL/min, or eGFR is less than 30 mL/min). 4.Patients with history of convulsant disease such as epilepsy. 5.Patients who took quinolones for current pneumonia. 6.Patients with episodes of apparent aspiration. 7.Patients with severe underlying diseases such as advanced cancer, primary lung cancer, metastatic lung cancer, severe heart failure and severe respiratory failure. 8.Patients with cystic fibrosis, AIDS, pneumocystis pneumonia, or active pulmonary tuberculosis. 9.Patients with pneumonia severity of PORT score V. 10.Patients whose participation in the study may put them at disadvantages.
研究者
相似试验
已完成
不适用
Effectiveness of pyrroloquinone quinone amino acid on mental status of Japanese subjectsHealthy adultJPRN-UMIN000032270Kagawa Nutrition University50
已完成
3 期
The effect of quinolone-containing regimens for the treatment of Helicobacter pylori infection.Helicobacter pylori infection.Helicobacter pylori [H.pylori] as the cause of diseases classified to other chaptersIRCT2012101311101N1Shiraz University of Medical Sciences140
招募中
2 期
Evaluation of Efficacy and Safety of Thymoquinone compared to Best supportive care in Patients with COVID-19CTRI/2020/05/025167Intas Pharmaceuticals Ltd
尚未招募
4 期
Efficacy and safety of chloroquine for the treatment of uncomplicated Plasmodium vivax malaria in Mae Hong Son and Kanchanaburi provinces in Thailandncomplicated vivax malaria patientsUncomplicated vivax malaria patientsInfection - Other infectious diseasesACTRN12610000554066Bureau of Vector-borne Disease100
尚未招募
不适用
Efficacy and safety of chloroquine for the treatment of Plasmodium vivax malaria in Teyarett District in Nouakchott and in the city of d'Atar (Adra Province) in Mauritania.Plasmodium vivax malariaInfection - Other infectious diseasesACTRN12613000411741Ministry of Health of Mauritania180